NCT06798805View on ClinicalTrials.gov

Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms

Active, not recruitingOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

August 8, 2024

Study Completion Date

August 31, 2025

Conditions
Essential Thrombocythemia (ET)Myelofibrosis (MF)Polycythemia Vera (PV)
Trial Locations (5)

25123

ASST Spedali Civili di Brescia, Brescia

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

42123

Arcispedale S. Maria Nuova - IRCCS, Reggio Emilia

47014

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori- IRST, Meldola

48100

Ospedale S.Maria delle Croci, Ravenna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER